Tibet Cheezheng Tibetan Medicine Co., Ltd.

Symbol: 002287.SZ

SHZ

22.31

CNY

Market price today

  • 20.5345

    P/E Ratio

  • 0.0000

    PEG Ratio

  • 11.83B

    MRK Cap

  • 0.02%

    DIV Yield

Tibet Cheezheng Tibetan Medicine Co., Ltd. (002287-SZ) Stock Price & Analysis

Shares Outstanding

530.17M

Gross Profit Margin

0.83%

Operating Profit Margin

0.27%

Net Profit Margin

0.29%

Return on Assets

0.09%

Return on Equity

0.16%

Return on Capital Employed

0.11%

Company general description and statistics

Sector: Healthcare
Industry: Biotechnology
CEO:Mr. Kailie Liu
Full-time employees:3091
City:Nyingchi
Address:2 Tibet Nyingchi Deji Road
IPO:2009-08-28
CIK:

Tibet Cheezheng Tibetan Medicine Co., Ltd. together with its subsidiaries, engages in the research, development, production, and sale of Tibetan medicine in China. It provides drug products in the areas of cardiovascular, respiratory, digestive, urinary and reproductive system, nervous system, musculoskeletal system, and gynecological disorders. The company was founded in 1995 and is based in Nyingchi, China. Tibet Cheezheng Tibetan Medicine Co., Ltd. operates as a subsidiary of Gansu Qizheng Industry Group Co., Ltd.

General Outlook

In simple terms, Tibet Cheezheng Tibetan Medicine Co., Ltd. has 530.173 M shares that people are buying and selling right now. When we look at how much money they make before expenses, they keep 0.833% as profit. This shows they're good at controlling costs and are financially stable. Their operating profit, which is money made from regular business activities, is 0.274%. This means they run their business efficiently. Lastly, after paying all their bills, they still have a profit of 0.286%. This tells us they're good at keeping money after all costs.

Return on Investments

The company's asset efficiency, represented by a robust 0.092% return, is a testament to Tibet Cheezheng Tibetan Medicine Co., Ltd.'s adeptness in optimizing resource deployment. Tibet Cheezheng Tibetan Medicine Co., Ltd.'s utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of 0.165%. Furthermore, the proficiency of Tibet Cheezheng Tibetan Medicine Co., Ltd. in capital utilization is underscored by a remarkable 0.110% return on capital employed.

Stock Prices

Tibet Cheezheng Tibetan Medicine Co., Ltd.'s stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $22, while its low point bottomed out at $21.56. This variance in figures offers investors a lucid insight into the roller-coaster ride that is Tibet Cheezheng Tibetan Medicine Co., Ltd.'s stock market.

Liquidity Ratios

Analyzing 002287.SZ liquidity ratios reveals its financial health of the firm. The current ratio of 256.53% gauges short-term asset coverage for liabilities. The quick ratio (243.33%) assesses immediate liquidity, while the cash ratio (32.40%) indicates cash reserves.

cards.indicatorcards.value
Current Ratio256.53%
Quick Ratio243.33%
Cash Ratio32.40%

Profitability Ratios

002287.SZ profitability indicators offer a lens into its earnings landscape. A pretax profit margin of 32.39% underscores its earnings before tax deductions. The effective tax rate stands at 9.91%, revealing its tax efficiency. The net income per EBT, 88.31%, and the EBT per EBIT, 118.43%, provide insights into its earnings hierarchy. Lastly, with an EBIT per revenue ratio of 27.35%, we grasp its operational profitability.

cards.indicatorcards.value
Pretax Profit Margin32.39%
Effective Tax Rate9.91%
Net Income per EBT88.31%
EBT per EBIT118.43%
EBIT per Revenue27.35%

Operational Efficiency

Operational metrics shed light on its business agility. With an operating cycle of 2.57, it details the span from stock purchase to revenue. The 2 days it takes to settle debts showcases its creditor relations.

cards.indicatorcards.value
Days of Sales Outstanding243
Days of Inventory Outstanding169
Operating Cycle287.78
Days of Payables Outstanding276
Cash Conversion Cycle12
Receivables Turnover3.06
Payables Turnover1.32
Inventory Turnover2.17
Fixed Asset Turnover1.23
Asset Turnover0.32

Cash Flow Ratios

Peering into the cash flow metrics reveals liquidity and operational efficiency. The operating cash flow per share, 2.30, and free cash flow per share, 1.86, depict cash generation on a per-share basis. The cash per share value, 4.46, showcases liquidity position. A payout ratio of 0.38 highlights the portion of earnings distributed as dividends. Lastly, the operating cash flow sales ratio, 0.60, offers insight into cash flow relative to sales.

cards.indicatorcards.value
Operating Cash Flow per Share2.30
Free Cash Flow per Share1.86
Cash per Share4.46
Payout Ratio0.38
Operating Cash Flow Sales Ratio0.60
Free Cash Flow to Operating Cash Flow Ratio0.81
Cash Flow Coverage Ratio0.79
Short Term Coverage Ratio2.55
Capital Expenditure Coverage Ratio5.19
Dividend Paid and Capex Coverage Ratio2.68
Dividend Payout Ratio0.02

Debt and Leverage Ratios

Diving into debt and leverage metrics unveils the company's financial structure. The debt ratio, at 24.44%, highlights its total liabilities relative to assets. With a debt-equity ratio of 0.41, we discern the balance between debt and equity financing. The long-term debt to capitalization, 22.19%, and total debt to capitalization, 29.27%, ratios shed light on its capital structure. An interest coverage of 8.81 indicates its ability to manage interest expenses.

cards.indicatorcards.value
Debt Ratio24.44%
Debt Equity Ratio0.41
Long Term Debt to Capitalization22.19%
Total Debt to Capitalization29.27%
Interest Coverage8.81
Cash Flow to Debt Ratio0.79
Company Equity Multiplier1.69

Per Share Data

Speaking about the per share data offers a perceptive view of financial distribution. The revenue per share, 3.79, provides a glimpse into top-line earnings distributed across each share. Net income per share, 1.10, reflects the portion of profit attributed to each share. The book value per share, 7.02, represents the net asset value distributed per share, while the tangible book value per share, 6.81, excludes intangible assets.

cards.indicatorcards.value
Revenue Per Share3.79
Net Income Per Share1.10
Book Value Per Share7.02
Tangible Book Value Per Share6.81
Shareholders Equity Per Share7.02
Interest Debt Per Share3.02
Capex Per Share-0.44

Growth Ratios

Delving into growth metrics provides a snapshot of financial expansion. The revenue growth rate, -1.69%, indicates top-line expansion, while the gross profit growth, -5.39%, reveals profitability trends. EBIT growth, -10.60%, and operating income growth, -10.60%, offer insights into operational profitability progression. The net income growth, 22.99%, showcases bottom-line expansion, and the EPS growth, 23.60%, measures the growth in earnings per share.

cards.indicatorcards.value
Revenue Growth-1.69%
Gross Profit Growth-5.39%
EBIT Growth-10.60%
Operating Income Growth-10.60%
Net Income Growth22.99%
EPS Growth23.60%
EPS Diluted Growth23.60%
Weighted Average Shares Growth-0.01%
Weighted Average Shares Diluted Growth-0.01%
Dividends per Share Growth-35.37%
Operating Cash Flow Growth240.19%
Free Cash Flow Growth5446.36%
10-Year Revenue Growth per Share104.43%
5-Year Revenue Growth per Share64.75%
3-Year Revenue Growth per Share35.77%
10-Year Operating CF Growth per Share382.74%
5-Year Operating CF Growth per Share93.49%
3-Year Operating CF Growth per Share306.02%
10-Year Net Income Growth per Share168.54%
5-Year Net Income Growth per Share81.28%
3-Year Net Income Growth per Share43.44%
10-Year Shareholders Equity Growth per Share160.35%
5-Year Shareholders Equity Growth per Share82.28%
3-Year Shareholders Equity Growth per Share41.67%
10-Year Dividend per Share Growth per Share72.36%
3-Year Dividend per Share Growth per Share13.56%
Receivables Growth-21.12%
Inventory Growth22.35%
Asset Growth7.00%
Book Value per Share Growth11.53%
Debt Growth-8.86%
R&D Expense Growth-8.27%
SGA Expenses Growth12.79%

Other Metrics

Venturing into other key metrics unveils diverse facets of financial performance. The enterprise value, 13,066,910,769.62, captures the company's total value, considering both debt and equity. Income quality, 1.67, assesses the reliability of reported earnings. The sales, general, and administrative to revenue ratio, 0.03, gauges operational efficiency, while the research and development to revenue, 2.51%, highlights investment in innovation. The ratio of intangibles to total assets, 5.58%, indicates the value of non-physical assets, and capex to operating cash flow, -24.16%, measures reinvestment capability.

cards.indicatorcards.value
Enterprise Value13,066,910,769.62
Income Quality1.67
Sales General and Administrative to Revenue0.03
Research and Development to Revenue2.51%
Intangibles to Total Assets5.58%
Capex to Operating Cash Flow-24.16%
Capex to Revenue-11.68%
Capex to Depreciation-245.18%
Graham Number13.16
Return on Tangible Assets9.77%
Graham Net Net1.15
Working Capital1,949,149,727
Tangible Asset Value3,612,430,936
Net Current Asset Value859,937,425
Average Receivables752,376,460
Average Payables174,537,646
Average Inventory142,053,528.5
Days Sales Outstanding120
Days Payables Outstanding244
Days of Inventory On Hand149
ROIC7.97%
ROE0.16%

Valuation Ratios

Exploring the valuation ratios offers insights into perceived market value. The price to book value ratio, 3.21, and the price to book ratio, 3.21, reflect the market's valuation relative to the company's book value. The price to sales ratio, 5.87, provides a perspective on valuation in relation to sales. Ratios like price to free cash flows, 12.13, and price to operating cash flows, 9.79, gauge market valuation against cash flow metrics.

cards.indicatorcards.value
Price Book Value Ratio3.21
Price to Book Ratio3.21
Price to Sales Ratio5.87
Price Cash Flow Ratio9.79
Enterprise Value Multiple17.97
Price Fair Value3.21
Price to Operating Cash Flow Ratio9.79
Price to Free Cash Flows Ratio12.13
Price to Tangible Book Ratio3.21
Enterprise Value to Sales6.50
Enterprise Value Over EBITDA23.25
EV to Operating Cash Flow13.45
Earnings Yield4.87%
Free Cash Flow Yield6.18%
security
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
Eugene Alexeev
NumFin Founder and investing enthusiast

Frequently Asked Question

How many company shares are outstanding in 2024?

There are stock number shares outstanding of Tibet Cheezheng Tibetan Medicine Co., Ltd. (002287.SZ) on the SHZ in 2024.

What is P/E ratio of enterprise in 2024?

The current P/E ratio of enterprise is 20.535 in 2024.

What is the ticker symbol of Tibet Cheezheng Tibetan Medicine Co., Ltd. stock?

The ticker symbol of Tibet Cheezheng Tibetan Medicine Co., Ltd. stock is 002287.SZ.

What is company IPO date?

IPO date of Tibet Cheezheng Tibetan Medicine Co., Ltd. is 2009-08-28.

What is company current share price?

Current share price is 22.310 CNY.

What is stock market cap today?

The market cap of stock today is 11828159630.000.

What is PEG ratio in 2024?

The current 0.000 is 0.000 in 2024.

What is the number of employees in 2024?

In 2024 the company has 3091.